3 Minute Read
May 20, 2025, the U.S. Department of Health and Human Services (HHS) issued a significant update on the Executive Order “Delivering Most Favored Nation Prescription Drug Pricing to...
5 Minute Read
Part 2 of our blog examines how new distribution models and market access trends will impact future pharmaceutical strategy.
4 Minute Read
The pharmaceutical industry is facing unprecedented challenges as market access dynamics continue to evolve. To navigate these complexities, companies must rethink channel, pricing, contracting, and patient access strategies.
5 Minute Read
Navigate market access issues with insights on 10 common warning signs, including outdated legacy mindsets, inadequate data sources, and operational silos.